ComplianceOnline

FDA Premarket Review of New and Modified Tobacco Products

Instructor: Azim Chowdhury
Product ID: 703127
  • Duration: 60 Min

recorded version

$229.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: May-2014

Training CD / USB Drive

$299.00
One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This training on FDA regulatory requirements for tobacco products will focus on the premarket review of new and modified tobacco products. It will also discuss the impact of FDA deeming regulation for of e- cigarettes and novel tobacco products on premarket authorization requirements.

Why Should You Attend:

On June 22, 2009, the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) became law, and amended the Federal Food, Drug and Cosmetic Act to give the Agency authority to regulate the manufacture, labeling, distribution, and marketing of tobacco products in the United States.

To bring a “new” tobacco product to the market will require obtaining FDA pre-market authorization by either demonstrating that the new product is substantially equivalent to a predicate product that was on the market as of the “Grandfather Date,” or submitting a new tobacco product application pursuant to Section 910 of the Tobacco Control Act. Companies looking to market their products with claims of either “reduced risk” or “reduced exposure” will need to prepare and submit a Section 911 Modified Risk Tobacco Product application to FDA. These premarket authorization requirements for now and modified risk tobacco products will also likely apply to currently unregulated products, such as e-cigarettes, once those products are captured within FDA’s authority pursuant to the upcoming Deeming Regulation.

This webinar will focus on FDA’s regulatory requirements of new and modified tobacco products. The instructor will discuss premarket authorization requirements including Section 910 new tobacco product application and Section 905(j) substantial equivalence report.

Areas Covered in the Webinar:

  • Premarket Review of New and Modified Tobacco Products
  • Section 910 New Tobacco Product Application
  • Section 905(j) Substantial Equivalence Report
  • Section 905(j)(3) Minor Modification Exemption
  • Section 911 Modified Risk Tobacco Product Application
  • What E-Cigarettes and Other Tobacco Products Can Expect

Who Will Benefit:

  • General Counsel and Management of tobacco companies, e-cigarette companies, etc.
  • Regulatory Compliance Associates and Managers
  • Medical professionals, public health and consumer advocates, and other individuals working in the smoking control/ harm reduction area
  • Regulatory affairs professionals and scientists who work in this area
  • Manufacturers and importers of e-cigarettes and other novel tobacco products
  • Suppliers to Tobacco Industry

Instructor Profile:

Azim Chowdhury, is an Attorney at the law firm of Keller and Heckman LLP in Washington, DC. In this role, he advises domestic and foreign corporations in matters of FDA and international regulatory compliance. In particular, he assists corporations in establishing clearances for food and drug additives in the U.S., Canada, and European Union, with an emphasis on indirect additives used in food-contact materials. Mr. Chowdhury has also developed expertise in tobacco product regulation and has experience representing tobacco manufacturers and suppliers, including electronic cigarette companies, in FDA regulatory matters. He is also a frequent contributor to the Food and Drug Law Institute’s (FDLI) Update Magazine, currently serves on the Editorial Advisory Board of the Food and Drug Law Journal, and is edited and co-authored FDLI’s first tobacco-exclusive publication, Tobacco Regulation and Compliance: An Essential Resource. Mr. Chowdhury received a BA and BS from Johns Hopkins University, a MBA from the University of Maryland Robert H. Smith School of Business and a JD, cum laude, from the University of Maryland School of Law. You can follow Mr. Chowdhury on Twitter @ECIGattorney.

Follow us :
Upcoming In-person Seminars by EX-FDA OFFICIALS
PV (Pharmacovigilance) Audit Strategy Planning

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading